经皮内镜椎间孔入路椎间盘髓核摘除术治疗腰椎间盘突出症的效果

摘要

Objective To evaluate the clinical efficacy of percutaneous transforaminal endoscopic treatment for lumbar disc herniation.Methods From January 2013 to January 2017,30 patients with lumbar disc herniation were treated with percutaneous transforaminal endoscope.The evaluation based on visual analogue scale (VAS)and Macnab low back pain assessment standards.Results The average follow-up time was 6 months (ranged from 3 to 12 months).Lower extremity VAS score decreased from (8.167-±0.874) before surgery to (1.567±0.504) postoperative 3 days and (1.067.± 0.254)postoperative 4 weeks,(0.967±0.183) postoperative 12 weeks,the differences were statistically significant (P＜0.05).According to Macnab low back pain assessment standards,excellent in 18 cases,good in 9 cases,fair in 2 cases,poor in 1 case,the excellent and good rate was 90％.Conclusion Percutaneous transforaminal endoscope in the treatment of lumbar intervertebral disc herniation has excellent and good results,it should be the preferred treatment for lumbar disc herniation.%目的 探讨经皮内镜椎间孔入路腰椎间盘髓核摘除术治疗腰椎间盘突出症的疗效.方法 2013-01-2017-01对30例腰椎间盘突出症患者行经皮内镜椎间孔入路腰椎间盘髓核摘除术治疗,疗效评定依据视觉模拟量表(Visual Analogue Scale,VAS)、Macnab腰腿痛评定标准.结果 随访3～12个月,平均6个月.术前VAS评分(8.166±0.874)分,术后3天(1.567±0.504)分,术后4周(1.067.±0.254)分,术后12周(0.967±0.183)分,手术前后结果差异有统计学意义(P＜0.05);Macnab腰腿痛评定标准结果为优18例,良9例,可3例,差0例,优良率90％.结论 经皮内镜椎间孔入路腰椎间盘髓核摘除术治疗腰椎间盘突出症是一种优化手术方法.